Basket cover image
15 handpicked stocks

Synthetic-Bio Foundries

Discover companies that are programming living cells to create the materials of tomorrow. These carefully selected stocks represent pioneers in replacing petrochemical processes with cleaner, more efficient biological alternatives - essentially turning microbes into tiny manufacturing plants.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 1 day ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

DNA

Ginkgo Bioworks Holdings Inc

DNA

Current price

$14.18

Operates a leading cell programming platform, or 'foundry,' to design custom organisms for a wide range of industrial applications.

TWST

Twist Bioscience Corp

TWST

Current price

$28.22

Provides the fundamental building blocks for synthetic biology through its silicon-based DNA synthesis platform.

CDXS

Codexis, Inc.

CDXS

Current price

$3.10

Specializes in engineering and supplying high-performance enzymes used to create sustainable manufacturing processes.

About This Group of Stocks

1

Our Expert Thinking

Synthetic biology represents a manufacturing revolution where engineered microorganisms replace industrial chemistry. These companies are creating cellular factories that can produce everything from fragrances to fuels more sustainably. This group captures both the foundry platforms and the essential tools enabling this bio-industrial transformation.

2

What You Need to Know

This collection spans diverse sectors including gene editing, DNA synthesis, enzyme development, and biofuel production. Consider it a high-growth satellite position that offers exposure to the convergence of biology, technology and manufacturing. The integration of AI is accelerating development timelines across the entire sector.

3

Why These Stocks

We've selected companies with scalable technology platforms, strong intellectual property, and clear commercialization paths. Our picks include both the "foundries" themselves and the "picks and shovels" companies that provide essential tools like DNA synthesis and sequencing technology that make this new form of manufacturing possible.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+136.82%

Group Performance Snapshot

136.82%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 136.82% over the next year.

10 of 14

Stocks Rated Buy by Analysts

10 of 14 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🧬

Biology's Industrial Revolution

These companies aren't just creating products - they're reinventing how things are made. By programming cells instead of chemicals, they're pioneering manufacturing methods that could make traditional factories obsolete.

🤖

AI Is Supercharging Development

Artificial intelligence is dramatically accelerating what these bio-foundries can achieve. Companies integrating AI into their platforms are compressing years of research into months, potentially leapfrogging competitors.

🌱

The Sustainable Manufacturing Shift

As corporations face pressure to reduce environmental impact, these bio-alternatives are becoming increasingly attractive. These stocks represent the companies building cleaner production methods that major industries will need to adopt.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Consumer Caution: Value Prevails

Consumer Caution: Value Prevails

A sharp drop in consumer sentiment, driven by persistent inflation fears, signals a potential shift in household spending. This theme focuses on companies poised to benefit as consumers prioritize essential goods and seek value.

View stocks
Refining a New Opportunity: Venezuelan Crude Returns

Refining a New Opportunity: Venezuelan Crude Returns

Following a renewed U.S. license, Chevron has resumed oil shipments from Venezuela, creating a new supply of heavy crude for the market. This development presents a potential investment opportunity in U.S. refiners and logistics firms positioned to benefit from this strategic shift.

View stocks
Consumer Strength: The Retail Rebound

Consumer Strength: The Retail Rebound

A surprising surge in U.S. retail sales, driven by strong automotive and home furnishing purchases, signals continued consumer strength despite economic headwinds. This theme focuses on retailers and manufacturers in these key discretionary sectors that are benefiting from the robust consumer demand.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.